Arrowhead Pharmaceuticals Inc (ARWR) Common Stock USD0.001
$1.57
(3.34%)
- Add to watchlist
- This stock can be held in a
$1.57
(3.34%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
$1.57
(3.34%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
Listed below are trades carried out by directors and other individuals which are required to be notified to the market.
| Date | Name | Position (if held) | Deal type | Number of shares dealt |
Price | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|---|
| N/A | There were no director deals placed within the selected time period of 3 months | ||||||
| N/A | There were no director deals placed within the selected time period of 6 months | ||||||
| 05 Jan 2022 | Hamilton, James C. | Senior Vice President | Sell (tax related) | 6,250.00 | $61.72 | $385,772.90 | 155,625.00 |
| 05 Jan 2022 | Myszkowski, Kenneth Allen | CFO | Sell (tax related) | 40,000.00 | $61.70 | $2,467,940.96 | 464,005.00 |
| 05 Jan 2022 | O'Brien, Patrick | General Counsel | Sell (tax related) | 32,500.00 | $61.72 | $2,005,875.26 | 348,875.00 |
| 04 Jan 2022 | Hamilton, James C. | Senior Vice President | Sell (tax related) | 19,375.00 | $65.49 | $1,268,818.32 | 161,875.00 |
| 03 Jan 2022 | De Backer, Marianne | Independent Director | Sell (tax related) | 4,500.00 | $64.71 | $291,176.84 | 17,000.00 |
| 03 Jan 2022 | Perry, Michael S (Mike) | N/A | Sell (tax related) | 4,500.00 | $64.71 | $291,192.40 | 85,500.00 |
| 03 Jan 2022 | Olukotun, Adeoye Yaovi (Oye) | Director | Sell (tax related) | 4,050.00 | $64.75 | $262,233.04 | 4,950.00 |
| 03 Jan 2022 | Waddill, William D | Independent Director | Sell (tax related) | 4,500.00 | $64.72 | $291,244.28 | 25,750.00 |
| 28 Dec 2021 | Ferrari, Mauro | Independent Director | Sell (tax related) | 3,400.00 | $66.82 | $227,188.00 | 36,571.00 |
| 28 Dec 2021 | Given, Douglass Bruce | Chairman of the Board | Regular purchase transaction | 655.00 | $66.37 | $43,472.35 | 109,868.00 |
| 15 Dec 2021 | Anzalone, Christopher Richard | President/CEO | Sell (tax related) | 60,000.00 | $67.56 | $4,053,431.46 | 3,219,022.00 |
| 19 Nov 2021 | San Martin, Javier | Chief Level Officer | Sell (tax related) | 19,500.00 | $69.31 | $1,351,589.00 | 111,000.00 |
| 22 Oct 2021 | Anzalone, Christopher Richard | President/CEO | Regular sell transaction (market) | 50,000.00 | $65.63 | $3,281,531.60 | 3,279,022.00 |
| 20 Oct 2021 | Anzalone, Christopher Richard | President/CEO | Regular sell transaction (market) | 15,000.00 | $66.23 | $993,450.00 | 3,329,022.00 |
| 13 Sep 2021 | Olukotun, Adeoye Yaovi (Oye) | Director | Sell (tax related) | 2,250.00 | $63.76 | $143,460.00 | 11,750.00 |
| 13 Sep 2021 | Olukotun, Adeoye Yaovi (Oye) | Director | Sell (award related) | 2,750.00 | $63.76 | $175,340.00 | 9,000.00 |
| 09 Sep 2021 | Given, Douglass Bruce | Chairman of the Board | Regular sell transaction (market) | 5,000.00 | $65.24 | $326,200.00 | 109,868.00 |
| Date | Name | Position (if held) | Deal type | Number of shares dealt |
Price | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|---|
| N/A | There were no director deals placed within the selected time period of 3 months | ||||||
| N/A | There were no director deals placed within the selected time period of 6 months | ||||||
| 15 Dec 2021 | Anzalone, Christopher Richard | President/CEO | Sell (tax related) | 60,000 | $67.56 | $4,053,431.46 | 3,219,022.00 |
| 22 Oct 2021 | Anzalone, Christopher Richard | President/CEO | Regular sell transaction (market) | 50,000 | $65.63 | $3,281,531.60 | 3,279,022.00 |
| 05 Jan 2022 | Myszkowski, Kenneth Allen | CFO | Sell (tax related) | 40,000 | $61.70 | $2,467,940.96 | 464,005.00 |
| 05 Jan 2022 | O'Brien, Patrick | General Counsel | Sell (tax related) | 32,500 | $61.72 | $2,005,875.26 | 348,875.00 |
| 19 Nov 2021 | San Martin, Javier | Chief Level Officer | Sell (tax related) | 19,500 | $69.31 | $1,351,589.00 | 111,000.00 |
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.